Drug Company ‘Shenanigans’ to Block Generics Come Under Federal Scrutiny

Health officials complain that pharmaceutical companies refuse to share samples needed to develop affordable generic versions of brand-name medicines.

from NYT > Home Page https://ift.tt/2vga54I